Nephroapp
Exam Cases MCQ Bank

Search

Find tools, topics, and resources

Welcome to Nephroapp
Sign in to keep your progress and bookmarks.
Log in Create account
Explore
Exam cases MCQ Bank Topics Plans and pricing
App
Explore NephroApp
Exam Cases MCQ Bank

Study

Exam cases
MCQ Bank
Fast Recaps
Plans and pricing
‹ Fast Recaps

🏥 CRRT / ICU

3 Fast Recaps

💧 Peritoneal Dialysis ⚡ Electrolytes & Acid–Base 🩸 Hemodialysis & Access 💓 Hypertension 🫀 Transplant 🔬 Glomerular 🪨 Tubular & Stones 🦴 CKD & Bone-Mineral ⭐ Special Topics 🚨 Acute Kidney Injury
CRRT prescription (septic ICU, dose, modes) Filtration fraction / filter clotting Septic AKI: resuscitation, bundle and RRT timing
4

CRRT prescription (septic ICU, dose, modes)

Open the full topic →
Fast Recap · 7 stops

CRRT prescription at a glance

100 kg, septic, anuric, K 7, on inotropes. Start now, run continuous, prescribe a deliverable dose, keep the filter alive.

  1. K 7 Indication Refractory K: start now, treat in parallel.
  2. Modality: CVVHDF Continuous for BP, diffusion for potassium.
  3. FF ! Circuit life Citrate first; filtration fraction when clotting.
1 Indications 2 Access & modality 3 Dose 4 Anticoagulation 5 Filtration fraction 6 Drugs & electrolytes 7 Discontinuation
  1. 1

    Stop 1 · Initiation

    Indications and timing of initiation

    Refractory K >6.0: start now. Acidosis alone: bicarbonate first.

    K 6.0 7 pH <7.20 HCO3
    1

    Potassium

    Therapy-resistant K >6.0: start immediately (ICU Rec 1.1).

    2

    Acidosis

    pH <7.20 alone: IV bicarbonate first, unless another urgent indication.

    3

    Volume or uraemia

    Refractory overload or uraemic complications (KDIGO 2012).

    Temporising therapy

    Calcium, insulin-dextrose, salbutamol while access is placed.

    Deferred initiation

    Deferred over early start (KDIGO 2026 draft, 1C); start for refractory complications.

    STARRT-AKI

    Death 43.9% vs 43.7%; more RRT dependence if accelerated.

    AKIKI

    No mortality difference; 49% of delayed never needed RRT.

    IDEAL-ICU

    Septic shock, 12 h vs 48 h: stopped for futility.

    BICARICU-2

    Bicarbonate to pH 7.30: mortality unchanged; less KRT (secondary).

    Memory hook

    “Refractory potassium starts the pump; acid alone gets the bicarbonate.” AKIKI 2: do not delay beyond standard triggers.

  2. 2

    Stop 2 · Set-up

    Vascular access and modality selection

    Right IJ, continuous, diffusive high dialysate flow: CVVHDF.

    R IJ CVVHDF
    Access · KDIGO 2012 Right IJ first
    Non-tunnelled dual-lumen, ultrasound-guided; chest film before use.
    Continuous vs intermittent Unstable → CRRT
    Instability, high inotropes, raised ICP, liver failure (KDIGO 2026 draft: CRRT or acute PD, 2C).
    IRRT: stable, rapid removal. SLED / PIRRT: acceptable if unstable.

    CRRT modalities

    UF only
    SCUF

    Water only; no effective solute clearance.

    Convection
    CVVH

    Small and middle molecules; needs replacement fluid.

    Diffusion
    CVVHD

    Small solutes; uses dialysate.

    Both
    CVVHDF

    Diffusion + convection: typical ICU choice.

    • Diffusion vs convection: similar outcomes; severe hyperkalaemia → high dialysate flow.
    • Pre-dilution: less clearance per litre (dose higher), less clotting.
    • Buffer: bicarbonate, not lactate, in shock or liver failure.
    Exam trap

    IHD on maximal inotropes. Hemodiafe 2006: no difference; ICRAKI 2026: IHD not noninferior, higher mortality.

  3. 3

    Stop 3 · Dose

    Dose prescription

    Prescribe 25–30 mL/kg/h to deliver 20–25 despite downtime.

    20–25 35–40 25–30 mL/kg/h prescribed
    Effluentthe dose= Dialysateflow+ Replacementflow+ Net UFfluid goal

    Dose = 24 h effluent ÷ weight ÷ 24. Actual weight; BMI ≥30: ideal or adjusted (KDIGO 2026 draft).

    Prescribe 25–30 mL/kg/h
    About 2,500–3,000 mL/h at 100 kg.
    Deliver 20–25 mL/kg/h
    ICU guideline, KDIGO 2012 and 2026 draft. No HVHF in sepsis.
    Blood flow QB 150–200 mL/min
    Clinical Handbook range 100–250 mL/min.
    Net UF Modest, individualised
    1.01–1.75 mL/kg/h appeared safe; >1.75 linked to mortality (observational).
    Worked example · account for downtime
    • 100 kg: 3,000 mL/h × 20 h = 60 L/day = 25 mL/kg/h delivered.
    • 75 kg: deliver 1,500–1,875 mL/h; prescribe ~2,250 mL/h.
    • Delivered dose low? Fix anticoagulation and circuit life first, then raise the rate.
    Memory hook
    25–30prescribe 20–25deliver 150–200QB ~3,000mL/h · 100 kg

    Slightly above target, no higher.

    Exam trap

    35–40 mL/kg/h as target. RENAL (40 vs 25): 90-day mortality 44.7% both. ATN: no benefit, more hypotension.

  4. 4

    Stop 4 · Anticoagulation

    Anticoagulation

    Regional citrate if no contraindication: longer filter life, fewer bleeds.

    citrate pre-filter Ca post-filter iCa <0.35 total:iCa 2.5

    Guideline recommendations

    KDIGO AKI 2012

    Suggests citrate over heparin (2B).

    ICU guideline 2026

    Citrate = heparin for outcomes; citrate if bleeding risk; UFH over LMWH.

    KDIGO 2026 draft

    Recommends citrate over heparin (1B); UFH, epoprostenol, nafamostat alternatives.

    Citrate set-up · mind the units Fixed to blood flow
    ACD-A mL/h ≈ 1.5 × QB in mL/min: QB 150 → 225 mL/h.
    Never 150% of QB in mL/h. Change citrate in proportion to QB.
    Citrate monitoring Two calcium targets
    Post-filter iCa <0.35 mmol/L; separate calcium to normal systemic iCa.
    iCa 4-hourly, then 6-hourly; total Ca ≥12-hourly; acid–base, lactate.

    Excess buffer

    Ratio <2.5 + alkalosis: review fluid buffer and citrate rate.

    Citrate accumulation

    Ratio >2.5, anion-gap acidosis, rising Ca need: treat hypocalcaemia, reduce citrate.

    Persists: stop citrate → bicarbonate CRRT, heparin or none.

    • Avoid citrate: progressive lactic acidosis + shock + severe liver failure. Either alone: monitor.
    • Other citrate issues: hypo/hypercalcaemia, hypernatraemia, hypomagnesaemia.
    • Heparin: trials 2,000–5,000 IU, then 7–10 IU/kg/h; Handbook 500–1,000 IU, then ~500 IU/h.
    • Heparin targets: aPTT q6h (RICH 45–60 s) or anti-Xa 0.3–0.6 IU/mL.
    • Acute HIT: argatroban (bivalirudin, danaparoid); citrate in subacute/remote HIT.
    • Bleeding: citrate; no anticoagulation only if unavoidable (pre-dilution, higher QB).
    Memory hook

    “Over 2.5, citrate is piling up. Under 2.5 with alkalosis, too much buffer.”

    Exam trap

    Calling accumulation an alkalosis. It is anion-gap acidosis, ratio >2.5. No shared ACT target.

  5. 5

    Stop 5 · Troubleshooting

    Filtration fraction and circuit troubleshooting

    High FF: haemoconcentration, protein deposition, circuit clotting.

    FF 35–40% keep <20–25%
    FFfraction= Total UFreplacement + net UF÷ Plasma flowQB × (1 − Hct)

    Dialysate not counted. Keep FF <20–25% (<20% if no anticoagulation).

    Worked example

    QB 200, Hct 0.30 → plasma flow 140 mL/min; UF 25 mL/min → FF ≈ 18%.

    Limitation: ignores pre-filter replacement.

    1. 1 · Increase blood flow

      Lowers FF; adjust citrate to the new QB.

    2. 2 · Pre-dilution

      Shift replacement fluid pre-filter.

    3. 3 · Optimise anticoagulation

      Post-filter iCa above target: citrate too low. Clotted: stop, change circuit, check coagulation.

    Circuit pressures

    • Rising pre-filter + TMP / pressure dropFilter clotting or fouling.
    • Very negative access pressureCatheter position, kinking or poor flow.
    • High return pressureClotted return lumen or kinked line.
    • Blood-leak alarmMembrane rupture: change the circuit at once.
    Emergency

    K still high on CRRT (e.g. 7.4): ECG, repeat K, IV calcium for ECG changes, temporising therapy; check circuit and flows; raise dialysate flow. No sustained dose escalation.

    Memory hook

    “Faster blood, dilute before, check the anticoagulant.”

  6. 6

    Stop 6 · Monitoring

    Drug dosing, electrolytes and nutrition

    Antibiotics, phosphate, magnesium and amino acids leave in effluent.

    full 1st dose q6h K · PO4 · Mg
    Antibiotics Full first dose
    Full, short infusion; maintenance by residual kidney + machine clearance.
    TDM: beta-lactams, vancomycin, aminoglycosides.
    Electrolytes K, PO4, Mg every 6 h
    Hypophosphataemia >50% (up to 65%): phosphate solution (~1 mmol/L) or supplement.
    Nutrition Amino acids leak
    0.2 g/L effluent → protein 1.2–1.5 g/kg/day (1.7 if hypercatabolic).
    Daily checks The rest of the board
    ABG, Hct (FF), aPTT if heparin, fluid balance, delivered dose, cultures.
    Red flags

    Severe hypotension, bradycardia, bleeding: stop and reassess. Air embolism, hypothermia. Antibiotic under-dosing.

  7. 7

    Stop 7 · Recovery

    Discontinuation

    Overload corrected, urine recovering, no new indication: trial off.

    >500 mL/day trial off
    Accepted criteria
    Urine >500 mL/day without diuretics, or ~2.4 L/day with.
    ICU guideline 2026
    Urine 300–600 mL/day without diuretics; K >5.5 or pH <7.3 predict failure.
    KDIGO 2026 draft
    >450 (no diuretics) or >2300 mL/24 h (diuretics) + 2-h CrCl ≥23 mL/min: predictors, not a rule.
    Exam trap

    Falling creatinine on active CRRT is not recovery.

    Memory hook

    “Dry first, urine back, no new reason: trial off.”

Pocket check

Rapid recall

What starts CRRT now in this patient?

Therapy-resistant K >6.0. Acidosis alone (pH <7.20) gets IV bicarbonate first.

Why CVVHDF, and why continuous?

Unstable → continuous; hyperkalaemia → diffusion, high dialysate flow.

Dose for a 100 kg patient?

Prescribe 25–30 mL/kg/h (~3,000 mL/h) to deliver 20–25; QB 150–200 mL/min.

What makes up the effluent?

Dialysate + replacement + net UF.

The FF equation and target?

FF = total UF ÷ plasma flow; plasma flow = QB × (1 − Hct). Keep <20–25%.

FF 35–40%, filter clotting?

Raise QB, shift replacement pre-filter, review anticoagulation. Clotted: hold, change circuit.

Citrate accumulation vs excess buffer?

Accumulation: ratio >2.5, anion-gap acidosis, rising Ca need. Excess buffer: alkalosis, ratio <2.5.

Dose and timing trials?

RENAL, ATN: more dose, no benefit. STARRT-AKI, AKIKI, IDEAL-ICU: earlier start, no benefit.

When do you trial off?

Overload corrected, urine >500 mL/day, no new indication.

Next tabs: detail, spoken answer, viva questions.

Sources: ICU RRT guideline 2026, KDIGO 2012 and 2026 draft, Clinical Handbook of Nephrology 2024.

47

Filtration fraction / filter clotting

Open the full topic →
Fast Recap · 6 stops

Filtration fraction at a glance

Remove too much plasma water relative to flow and blood haemoconcentrates in the filter, then clots. Keep FF under 20–25%.

  1. Qb × (1 − Hct) Plasma flow Blood flow corrected for haematocrit.
  2. Haemoconcentration Thick blood at the membrane.
  3. TMP Filter clotting A rising TMP warns first.
  1. 1

    Stop 1 · Definition

    Filtration fraction calculation

    Plasma flow, not blood flow: correct for haematocrit.

    UF plasma flow ~24% FF <20–25%
    FF = UF rate / plasma flowplasma flow = Qb × (1 − Hct)
    1

    Plasma flow

    Qb 150 mL/min, Hct 30%: 150 × 0.7 = 105 mL/min.

    2

    UF rate

    25 mL/min.

    3

    FF

    25/105 ≈ 24%: near the upper limit.

    Exam trap

    “UF rate over blood flow” forgets the (1 − Hct) correction.

  2. 2

    Stop 2 · Prescription

    CRRT prescription

    Subscribers only

Unlock the other 5 stops

Every drawing, memory hook and exam trap, the pocket check, the spoken answer, the viva questions and every section of this topic.

  1. Causes of filter clotting
  2. Management of high filtration fraction
  3. Circuit anticoagulation
  4. Monitoring and recurrent clotting
See the plans →
105

Septic AKI: resuscitation, bundle and RRT timing

Open the full topic →
Fast Recap · 6 stops

Septic AKI at a glance

Source and antibiotics first, resuscitate without drowning, protect the kidney, dialyse only for emergencies.

  1. 60% Sepsis hits the kidney Up to 60% of septic shock.
  2. 30 mL/kg MAP 65 Resuscitate, then reassess Balanced crystalloid, norepinephrine.
  3. RRT on emergencies Not creatinine alone; deferred start.
  1. 1

    Stop 1 · Priorities

    Initial resuscitation

    Source control and antibiotics within the hour, not dialysis.

    within the hour Abx
    1. Antibiotics + source control within the hour.

    2. 30 mL/kg balanced crystalloid within 3 hours, then dynamic measures.

    3. Norepinephrine to MAP 65; add vasopressin.

    4. Refractory shock: steroids.

    Not just flow

    Inflammation, microcirculation, endothelial and glycocalyx injury, mitochondria.

    So

    Don’t chase MAP or fluids beyond targets.

    Memory hook

    “Bugs, bag, pressor; then the kidney.”

  2. 2

    Stop 2 · Diagnosis

    Diagnostic evaluation

    Subscribers only

Unlock the other 5 stops

Every drawing, memory hook and exam trap, the pocket check, the spoken answer, the viva questions and every section of this topic.

  1. Fluid and vasopressor therapy
  2. KDIGO AKI care bundle
  3. Timing of renal replacement therapy
  4. Modality, dose and anticoagulation
See the plans →
Home All Topics Contact Us Terms of Service Privacy Policy Refund Policy Facebook YouTube Monawib

Tools: Nephrology tools · Radiology

Disclaimer: NephroApp is an independent educational platform and is not affiliated with, endorsed by, or sponsored by any licensing authority, examination provider, or textbook publisher. The MCQ Bank provides exam-style practice for educational purposes.

Nephroapp© 2026. All rights reserved.

Made with by Dr. Hossam Abohassan